| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.adeshwarmeditex.com | |
| Market Cap | 24.17 Cr. | |
| Enterprise Value(EV) | 41.32 Cr. | 2022-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.55 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | 30.49 | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 32.00 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 21.45 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 0.78 | Calculated using Price: 16.75 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.44 Cr. | 14,431,426 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company is one of the major, trusted, cGMP, CE, ISO 9001-2008 Certified manufacturer and exporter in the field of sterile surgical wound dressing products and medical disposables. | ||
| 1 Day |
|
-0.30% |
| 1 Week |
|
-1.47% |
| 1 Month |
|
-29.32% |
| 3 Month |
|
-40.18% |
| 6 Month |
|
-34.31% |
| 1 Year |
|
-37.15% |
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 9 years | 2012-03 | 2013-03 | 2014-03 | 2015-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 41.04 | 32.99 | 11.31 | 18.17 | 26.33 | 15.34 | 12.19 | 8.50 | 3.08 | |
| Return on Capital Employed (%) | 32.84 | 29.48 | 15.72 | 16.75 | 28.76 | 17.59 | 14.29 | 11.13 | 6.98 | |
| Return on Assets (%) | 6.66 | 8.93 | 3.83 | 6.58 | 10.52 | 5.89 | 4.30 | 2.87 | 1.18 |
| Particulars | 10 years | 2011-03 Rs. Cr. | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Shh. Funds | 1 | 3 | 5 | 6 | 6 | 14 | 16 | 19 | 21 | 31 | |
| Non Curr. Liab. | 1 | 2 | 3 | 3 | 3 | 1 | 6 | 7 | 6 | 4 | |
| Curr. Liab. | 9 | 8 | 7 | 7 | 7 | 18 | 22 | 29 | 36 | 37 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 11 | 12 | 15 | 15 | 16 | 33 | 44 | 55 | 62 | 72 | |
| Non Curr. Assets | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 7 | |
| Curr. Assets | 8 | 9 | 11 | 12 | 13 | 29 | 39 | 50 | 57 | 65 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 11 | 12 | 15 | 15 | 16 | 33 | 44 | 55 | 62 | 72 |
| Particulars | 10 years | 2011-03 Rs. Cr. | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Net Sales | 10 | 14 | 27 | 16 | 25 | 59 | 53 | 56 | 66 | 65 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | ||
| Total Income | 10 | 14 | 27 | 16 | 26 | 59 | 55 | 56 | 66 | 65 | |
| Total Expenditure | -9 | -12 | -24 | -14 | -23 | -53 | -49 | -51 | -61 | -61 | |
| PBIDT | 1 | 2 | 3 | 2 | 2 | 6 | 6 | 6 | 5 | 4 | |
| Interest | 0 | 0 | -1 | -1 | -2 | -2 | -3 | -2 | -2 | ||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Taxation | 0 | -1 | 0 | 0 | -1 | -1 | -1 | -1 | 0 | ||
| Exceptional Items | |||||||||||
| PAT | 0 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 2 | 1 | |
| Adjusted EPS | 55 | 2 | 2 | 1 | 2 | 3 | 2 | 4 | 2 | 1 |
| Particulars | 7 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | -1 | -6 | -1 | 3 | -2 | |||
| Cash Fr. Inv. | 0 | 0 | 2 | -1 | -1 | |||
| Cash Fr. Finan. | 1 | 6 | 0 | -3 | 4 | |||
| Net Change | 0 | 0 | 1 | -1 | 1 | |||
| Cash & Cash Eqvt | 1 | 1 | 2 | 1 | 2 |
|
Mon, 13 Mar 2023
Board Meeting Outcome for Re-Submission Of Outcome Of Board Meeting Held On 27Th February 2023 With reference to the e-mail received from BSE Ltd dated February 28 2022 in regards to Re-Submission of Outcome of Board Meeting held on 27th February 2023 we wish to re-submit the same with additional documents as required under Regulation 30 of SEBI (LODR) Regulations 2015. |
|
Mon, 27 Feb 2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday February 27 2023. 1. Taken a note of cessation of Mr. Siddharth Mulchand Talati Managing Director of the Company due to demise on Saturday 11 February 2023;2. Taken a note of the resignation tendered by Mr. Shailesh Vinayak Rajpure with effect from January 30 2023 due to pre-occupation;3. Considered and approved the appointment of Mr. Shailesh Vinayak Rajpure (DIN: 06758460) as an Additional Director (Executive) of the Company on the request of the Board;4. Authorized Mr. Shailesh Vinayak Rajpure (DIN: 06758460) Additional Director of the Company for various purposes;5. Authorised Ms. Shivani Tiwari Company Secretary Mr. Shailesh Rajpure Director for filing of various forms of the company;6. Considered surrendering of HDFC Life Sampoorn Samridhi Policy held in the name of Ms. Sitanshi Parikh maintained with HDFC Standard Life Insurance Company Limited with immediate effect. |
|
Mon, 13 Feb 2023
Announcement under Regulation 30 (LODR)-Demise In compliance of regulation 30 and 31A(6)(c) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we regret to inform about the sad demise of Shri Siddharth Mulchand Talati Managing Director and Promoter of the Company on Saturday February 11 2023.Further it is hereby informed that he would cease to be Promoter of the Company in accordance with Regulation 31A(6)(c) of the SEBI LODR Regulations 2015.The new promoter post the demise of Shri Siddharth Mulchand Talati will be his wife Smt Sucheta Siddharth Talati. |
| Mon, 27 Mar 2023 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Equities
M.F.
Sectors